Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/22/2017 05/23/2017 05/24/2017 05/25/2017 05/26/2017 Date
52.25(c) 52.6(c) 53.6(c) 53.5(c) 53.5(c) Last
244 319 220 386 251 108 315 759 156 460 Volume
+0.19% +0.67% +1.90% -0.19% 0.00% Change
More quotes
Financials ($)
Sales 2017 537 M
EBIT 2017 139 M
Net income 2017 95,9 M
Debt 2017 -
Yield 2017 -
Sales 2018 576 M
EBIT 2018 152 M
Net income 2018 103 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 18,58
P/E ratio 2018 17,50
Capi. / Sales2017 3,25x
Capi. / Sales2018 3,03x
Capitalization 1 742 M
More Financials
Company
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies to innovator and generic pharmaceutical companies.Its products include generic and branded APIs, controlled... 
Sector
Pharmaceuticals
Calendar
08/03Earnings Release
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
05/19 CAMBREX : invests $2.4m at former PharmaCore site
05/18 CAMBREX : invests $2.4m at former PharmaCore site
05/18 CAMBREX : Invests $2.4M in API Capacity at NC Facility
05/17 CAMBREX : Invests to increase pilot scale api capacity at its high point, nc fac..
05/16 CAMBREX : Invests to Increase Pilot Scale API Capacity at its High Point, NC Fac..
05/15 Cambrex to Present at the 2017 UBS Global Healthcare Conference
05/04 CAMBREX CO. (NYSE : CBM) reported earnings of $0.68 per share beating Walls Stre..
05/04 CAMBREX : posts 1Q profit
05/04 CAMBREX : Management's Discussion and Analysis of Financial Condition and Result..
05/04 CAMBREX CORP : Results of Operations and Financial Condition, Financial Statemen..
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
Latest Tweets
05/25Cambrex Co. $CBM Stake Boosted by Congress Asset Management Co. MA  
05/25Chatham Capital Group Inc. Acquires Shares of 14,500 Cambrex Co. $CBM  
05/23Cambrex Corporation (CBM) Presents At UBS Global Healthcare Conference 2017 -.. 
05/22#CBM could help transform #Botswana’s power sector  
05/20IronBridge Capital Management LP Has $12.039 Million Position in Cambrex Co. .. 
More tweets
Qtime:13
News from SeekingAlpha
05/23 Cambrex Corporation (CBM) Presents At UBS Global Healthcare Conference 2017 -..
05/06 Cambrex's (CBM) CEO Steve Klosk on Q1 2017 Results - Earnings Call Transcript
05/04 Cambrex beats by $0.20, beats on revenue
05/03 Notable earnings before Thursday?s open
03/22 Best Price-Positioned Integrated Oil & Gas Stocks, As Seen By Market-Makers
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 65,5 $
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Tom Vadaketh Chief Financial Officer & Vice President
Peter G. Tombros Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION-0.83%1 742
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.88%236 581
NOVARTIS AG6.75%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results